 | • レポートコード：MRC2102QY12117 • 出版社/出版日： / 2021年1月 • レポート形態：英文、PDF、132ページ • 納品方法：Eメール（受注後2~3営業日） • 産業分類：医薬品、医療 |
| Single User | ￥592,000 (USD4,000) | ▷ お問い合わせ |
| Multi User | ￥888,000 (USD6,000) | ▷ お問い合わせ |
| Enterprise License | ￥1,184,000 (USD8,000) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| QYリサーチ社の本調査レポートでは、世界の治療用組換えタンパク質市場について種類別（組換えヒトコラージュ、組換えヒト血清アルブミン）、用途別（医学、科学研究、その他）、地域別（米国、ヨーロッパ、中国、日本、東南アジア、インド）に区分して調査し、纏めました。2015年～2026年までの市場規模予測、主要プレイヤーの競争状況・市場シェア・企業情報、製造コスト分析、販売チャネル・流通業者・顧客情報、市場動向・機会・課題などのマーケットデータが記載されています。市場予測データは新型コロナウイルスの影響を反映させました。 ・治療用組換えタンパク質市場の概要 ・世界の主要地域別治療用組換えタンパク質市場規模2015-2026 ・主要プレイヤーの競争状況・市場シェア ・世界の治療用組換えタンパク質市場規模2015-2026：種類別（組換えヒトコラージュ、組換えヒト血清アルブミン） ・世界の治療用組換えタンパク質市場規模2015-2026：用途別（医学、科学研究、その他） ・治療用組換えタンパク質の米国市場規模2015-2020 ・治療用組換えタンパク質のヨーロッパ市場規模2015-2020 ・治療用組換えタンパク質の中国市場規模2015-2020 ・治療用組換えタンパク質の日本市場規模2015-2020 ・治療用組換えタンパク質の東南アジア市場規模2015-2020 ・治療用組換えタンパク質のインド市場規模2015-2020 ・主要プレイヤーの企業情報：事業概要・売上・企業動向 ・治療用組換えタンパク質の製造コスト分析 ・販売チャネル、流通業者、顧客 ・治療用組換えタンパク質の市場動向・機会・課題 ・調査の結論 |
Recombinant Therapeutic Protein are produced by using a technique called recombinant DNA or recombinant RNA to produce proteins. The method can be divided into in vitro method and in vivo method. Both approaches are premised on the use of genetic recombination techniques to obtain recombinant vectors attached to gene fragments that can be translated into target proteins and then transferred to host cells that can express target proteins to express specific recombinant governance protein molecules.
Market Analysis and Insights: Global Recombinant Therapeutic Protein Market
The global Recombinant Therapeutic Protein market size is projected to reach US$ XX million by 2026, from US$ XX million in 2020, at a CAGR of XX% during 2021-2026.
Global Recombinant Therapeutic Protein Scope and Market Size
The global Recombinant Therapeutic Protein market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Recombinant Therapeutic Protein market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by region (country), by Type and by Application for the period 2015-2026.
Segment by Type, the Recombinant Therapeutic Protein market is segmented into
Recombinant Human Collage
Recombinant Human Serum Albumin
Segment by Application, the Recombinant Therapeutic Protein market is segmented into
Medicine
Scientific Research
Others
The Recombinant Therapeutic Protein market is analysed and market size information is provided by regions (countries). Segment by Application, the Recombinant Therapeutic Protein market is segmented into United States, Europe, China, Japan, Southeast Asia, India and Rest of World.
The report includes region-wise market size for the period 2015-2026. It also includes market size and forecast by players, by Type, and by Application segment in terms of sales and revenue for the period 2015-2026.
Competitive Landscape and Recombinant Therapeutic Protein Market Share Analysis
Recombinant Therapeutic Protein market competitive landscape provides details and data information by players. The report offers comprehensive analysis and accurate statistics on revenue by the player for the period 2015-2020. It also offers detailed analysis supported by reliable statistics on revenue (global and regional level) by players for the period 2015-2020. Details included are company description, major business, company total revenue and the sales, revenue generated in Recombinant Therapeutic Protein business, the date to enter into the Recombinant Therapeutic Protein market, Recombinant Therapeutic Protein product introduction, recent developments, etc.
The major vendors covered:
Boehringer Ingelheim
Bristol-Myers Squibb
Celldex Therapeutics
Eli Liily
GlaxoSmithKline
Merck
Novartis
Regeneron Pharmaceuticals
Roche
Takeda
1 Recombinant Therapeutic Protein Market Overview
1.1 Recombinant Therapeutic Protein Product Scope
1.2 Recombinant Therapeutic Protein Segment by Type
1.2.1 Global Recombinant Therapeutic Protein Sales by Type (2020-2026)
1.2.2 Recombinant Human Collage
1.2.3 Recombinant Human Serum Albumin
1.3 Recombinant Therapeutic Protein Segment by Application
1.3.1 Global Recombinant Therapeutic Protein Sales Comparison by Application (2020-2026)
1.3.2 Medicine
1.3.3 Scientific Research
1.3.4 Others
1.4 Recombinant Therapeutic Protein Market Estimates and Forecasts (2015-2026)
1.4.1 Global Recombinant Therapeutic Protein Sales Growth Rate (2015-2026)
1.4.2 Global Recombinant Therapeutic Protein Revenue and Growth Rate (2015-2026)
1.4.3 Global Recombinant Therapeutic Protein Price Trends (2015-2026)
2 Recombinant Therapeutic Protein Estimate and Forecast by Region
2.1 Global Recombinant Therapeutic Protein Market Size by Region: 2015 VS 2020 VS 2026
2.2 Global Recombinant Therapeutic Protein Retrospective Market Scenario by Region (2015-2020)
2.2.1 Global Recombinant Therapeutic Protein Sales Market Share by Region (2015-2020)
2.2.2 Global Recombinant Therapeutic Protein Revenue Market Share by Region (2015-2020)
2.3 Global Recombinant Therapeutic Protein Market Estimates and Forecasts by Region (2021-2026)
2.3.1 Global Recombinant Therapeutic Protein Sales Estimates and Forecasts by Region (2021-2026)
2.3.2 Global Recombinant Therapeutic Protein Revenue Forecast by Region (2021-2026)
2.4 Geographic Market Analysis: Market Facts & Figures
2.4.1 United States Recombinant Therapeutic Protein Estimates and Projections (2015-2026)
2.4.2 Europe Recombinant Therapeutic Protein Estimates and Projections (2015-2026)
2.4.3 China Recombinant Therapeutic Protein Estimates and Projections (2015-2026)
2.4.4 Japan Recombinant Therapeutic Protein Estimates and Projections (2015-2026)
2.4.5 Southeast Asia Recombinant Therapeutic Protein Estimates and Projections (2015-2026)
2.4.6 India Recombinant Therapeutic Protein Estimates and Projections (2015-2026)
3 Global Recombinant Therapeutic Protein Competition Landscape by Players
3.1 Global Top Recombinant Therapeutic Protein Players by Sales (2015-2020)
3.2 Global Top Recombinant Therapeutic Protein Players by Revenue (2015-2020)
3.3 Global Recombinant Therapeutic Protein Market Share by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Recombinant Therapeutic Protein as of 2019)
3.4 Global Recombinant Therapeutic Protein Average Price by Company (2015-2020)
3.5 Manufacturers Recombinant Therapeutic Protein Manufacturing Sites, Area Served, Product Type
3.6 Manufacturers Mergers & Acquisitions, Expansion Plans
3.7 Primary Interviews with Key Recombinant Therapeutic Protein Players (Opinion Leaders)
4 Global Recombinant Therapeutic Protein Market Size by Type
4.1 Global Recombinant Therapeutic Protein Historic Market Review by Type (2015-2020)
4.1.1 Global Recombinant Therapeutic Protein Sales Market Share by Type (2015-2020)
4.1.2 Global Recombinant Therapeutic Protein Revenue Market Share by Type (2015-2020)
4.1.3 Global Recombinant Therapeutic Protein Price by Type (2015-2020)
4.2 Global Recombinant Therapeutic Protein Market Estimates and Forecasts by Type (2021-2026)
4.2.1 Global Recombinant Therapeutic Protein Sales Forecast by Type (2021-2026)
4.2.2 Global Recombinant Therapeutic Protein Revenue Forecast by Type (2021-2026)
4.2.3 Global Recombinant Therapeutic Protein Price Forecast by Type (2021-2026)
5 Global Recombinant Therapeutic Protein Market Size by Application
5.1 Global Recombinant Therapeutic Protein Historic Market Review by Application (2015-2020)
5.1.1 Global Recombinant Therapeutic Protein Sales Market Share by Application (2015-2020)
5.1.2 Global Recombinant Therapeutic Protein Revenue Market Share by Application (2015-2020)
5.1.3 Global Recombinant Therapeutic Protein Price by Application (2015-2020)
5.2 Global Recombinant Therapeutic Protein Market Estimates and Forecasts by Application (2021-2026)
5.2.1 Global Recombinant Therapeutic Protein Sales Forecast by Application (2021-2026)
5.2.2 Global Recombinant Therapeutic Protein Revenue Forecast by Application (2021-2026)
5.2.3 Global Recombinant Therapeutic Protein Price Forecast by Application (2021-2026)
6 United States Recombinant Therapeutic Protein Market Facts & Figures
6.1 United States Recombinant Therapeutic Protein Sales Market Share by Company (2015-2020)
6.2 United States Recombinant Therapeutic Protein Sales Market Share by Type (2015-2020)
6.3 United States Recombinant Therapeutic Protein Sales Market Share by Application (2015-2020)
7 Europe Recombinant Therapeutic Protein Market Facts & Figures
7.1 Europe Recombinant Therapeutic Protein Sales Market Share by Company (2015-2020)
7.2 Europe Recombinant Therapeutic Protein Sales Market Share by Type (2015-2020)
7.3 Europe Recombinant Therapeutic Protein Sales Market Share by Application (2015-2020)
8 China Recombinant Therapeutic Protein Market Facts & Figures
8.1 China Recombinant Therapeutic Protein Sales Market Share by Company (2015-2020)
8.2 China Recombinant Therapeutic Protein Sales Market Share by Type (2015-2020)
8.3 China Recombinant Therapeutic Protein Sales Market Share by Application (2015-2020)
9 Japan Recombinant Therapeutic Protein Market Facts & Figures
9.1 Japan Recombinant Therapeutic Protein Sales Market Share by Company (3015-3030)
9.2 Japan Recombinant Therapeutic Protein Sales Market Share by Type (2015-2020)
9.3 Japan Recombinant Therapeutic Protein Sales Market Share by Application (2015-2020)
10 Southeast Asia Recombinant Therapeutic Protein Market Facts & Figures
10.1 Southeast Asia Recombinant Therapeutic Protein Sales Market Share by Company (2015-2020)
10.2 Southeast Asia Recombinant Therapeutic Protein Sales Market Share by Type (2015-2020)
10.3 Southeast Asia Recombinant Therapeutic Protein Sales Market Share by Application (2015-2020)
11 India Recombinant Therapeutic Protein Market Facts & Figures
11.1 India Recombinant Therapeutic Protein Sales Market Share by Company (2015-2020)
11.2 India Recombinant Therapeutic Protein Sales Market Share by Type (2015-2020)
11.3 India Recombinant Therapeutic Protein Sales Market Share by Application (2015-2020)
12 Company Profiles and Key Figures in Recombinant Therapeutic Protein Business
12.1 Boehringer Ingelheim
12.1.1 Boehringer Ingelheim Corporation Information
12.1.2 Boehringer Ingelheim Business Overview
12.1.3 Boehringer Ingelheim Recombinant Therapeutic Protein Sales, Revenue and Gross Margin (2015-2020)
12.1.4 Boehringer Ingelheim Recombinant Therapeutic Protein Products Offered
12.1.5 Boehringer Ingelheim Recent Development
12.2 Bristol-Myers Squibb
12.2.1 Bristol-Myers Squibb Corporation Information
12.2.2 Bristol-Myers Squibb Business Overview
12.2.3 Bristol-Myers Squibb Recombinant Therapeutic Protein Sales, Revenue and Gross Margin (2015-2020)
12.2.4 Bristol-Myers Squibb Recombinant Therapeutic Protein Products Offered
12.2.5 Bristol-Myers Squibb Recent Development
12.3 Celldex Therapeutics
12.3.1 Celldex Therapeutics Corporation Information
12.3.2 Celldex Therapeutics Business Overview
12.3.3 Celldex Therapeutics Recombinant Therapeutic Protein Sales, Revenue and Gross Margin (2015-2020)
12.3.4 Celldex Therapeutics Recombinant Therapeutic Protein Products Offered
12.3.5 Celldex Therapeutics Recent Development
12.4 Eli Liily
12.4.1 Eli Liily Corporation Information
12.4.2 Eli Liily Business Overview
12.4.3 Eli Liily Recombinant Therapeutic Protein Sales, Revenue and Gross Margin (2015-2020)
12.4.4 Eli Liily Recombinant Therapeutic Protein Products Offered
12.4.5 Eli Liily Recent Development
12.5 GlaxoSmithKline
12.5.1 GlaxoSmithKline Corporation Information
12.5.2 GlaxoSmithKline Business Overview
12.5.3 GlaxoSmithKline Recombinant Therapeutic Protein Sales, Revenue and Gross Margin (2015-2020)
12.5.4 GlaxoSmithKline Recombinant Therapeutic Protein Products Offered
12.5.5 GlaxoSmithKline Recent Development
12.6 Merck
12.6.1 Merck Corporation Information
12.6.2 Merck Business Overview
12.6.3 Merck Recombinant Therapeutic Protein Sales, Revenue and Gross Margin (2015-2020)
12.6.4 Merck Recombinant Therapeutic Protein Products Offered
12.6.5 Merck Recent Development
12.7 Novartis
12.7.1 Novartis Corporation Information
12.7.2 Novartis Business Overview
12.7.3 Novartis Recombinant Therapeutic Protein Sales, Revenue and Gross Margin (2015-2020)
12.7.4 Novartis Recombinant Therapeutic Protein Products Offered
12.7.5 Novartis Recent Development
12.8 Regeneron Pharmaceuticals
12.8.1 Regeneron Pharmaceuticals Corporation Information
12.8.2 Regeneron Pharmaceuticals Business Overview
12.8.3 Regeneron Pharmaceuticals Recombinant Therapeutic Protein Sales, Revenue and Gross Margin (2015-2020)
12.8.4 Regeneron Pharmaceuticals Recombinant Therapeutic Protein Products Offered
12.8.5 Regeneron Pharmaceuticals Recent Development
12.9 Roche
12.9.1 Roche Corporation Information
12.9.2 Roche Business Overview
12.9.3 Roche Recombinant Therapeutic Protein Sales, Revenue and Gross Margin (2015-2020)
12.9.4 Roche Recombinant Therapeutic Protein Products Offered
12.9.5 Roche Recent Development
12.10 Takeda
12.10.1 Takeda Corporation Information
12.10.2 Takeda Business Overview
12.10.3 Takeda Recombinant Therapeutic Protein Sales, Revenue and Gross Margin (2015-2020)
12.10.4 Takeda Recombinant Therapeutic Protein Products Offered
12.10.5 Takeda Recent Development
13 Recombinant Therapeutic Protein Manufacturing Cost Analysis
13.1 Recombinant Therapeutic Protein Key Raw Materials Analysis
13.1.1 Key Raw Materials
13.1.2 Key Raw Materials Price Trend
13.1.3 Key Suppliers of Raw Materials
13.2 Proportion of Manufacturing Cost Structure
13.3 Manufacturing Process Analysis of Recombinant Therapeutic Protein
13.4 Recombinant Therapeutic Protein Industrial Chain Analysis
14 Marketing Channel, Distributors and Customers
14.1 Marketing Channel
14.2 Recombinant Therapeutic Protein Distributors List
14.3 Recombinant Therapeutic Protein Customers
15 Market Dynamics
15.1 Recombinant Therapeutic Protein Market Trends
15.2 Recombinant Therapeutic Protein Opportunities and Drivers
15.3 Recombinant Therapeutic Protein Market Challenges
15.4 Recombinant Therapeutic Protein Market Restraints
15.5 Porter’s Five Forces Analysis
16 Research Findings and Conclusion
17 Appendix
17.1 Research Methodology
17.1.1 Methodology/Research Approach
17.1.2 Data Source
17.2 Author List
17.3 Disclaimer
Table 1. Global Recombinant Therapeutic Protein Sales (MT) Growth Rate by Type (2020-2026) (US$ Million)
Table 2. Global Recombinant Therapeutic Protein Sales (MT) Comparison by Application (2020-2026) (US$ Million)
Table 3. Global Market Recombinant Therapeutic Protein Market Size (US$ Million) by Region:2015 VS 2020 &2026
Table 4. Global Recombinant Therapeutic Protein Sales (MT) by Region (2015-2020)
Table 5. Global Recombinant Therapeutic Protein Sales Market Share by Region (2015-2020)
Table 6. Global Recombinant Therapeutic Protein Revenue (US$ Million) Market Share by Region (2015-2020))
Table 7. Global Recombinant Therapeutic Protein Revenue Share by Region (2015-2020)
Table 8. Global Recombinant Therapeutic Protein Sales (MT) Forecast by Region (2021-2026)
Table 9. Global Recombinant Therapeutic Protein Sales Market Share Forecast by Region (2021-2026)
Table 10. Global Recombinant Therapeutic Protein Revenue (US$ Million) Forecast by Region (2021-2026)
Table 11. Global Recombinant Therapeutic Protein Revenue Share Forecast by Region (2021-2026)
Table 12. Global Recombinant Therapeutic Protein (MT) of Key Companies (2015-2020)
Table 13. Global Recombinant Therapeutic Protein Sales Share by Company (2015-2020)
Table 14. Global Recombinant Therapeutic Protein Revenue (US$ Million) by Company (2015-2020)
Table 15. Global Recombinant Therapeutic Protein Revenue Share by Company (2015-2020)
Table 16. Global Recombinant Therapeutic Protein by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Recombinant Therapeutic Protein as of 2019)
Table 17. Global Recombinant Therapeutic Protein Average Price (USD/MT) of Key Company (2015-2020)
Table 18. Manufacturers Recombinant Therapeutic Protein Manufacturing Sites and Area Served
Table 19. Manufacturers Recombinant Therapeutic Protein Product Type
Table 20. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 21. Main Points Interviewed from Key Recombinant Therapeutic Protein Players
Table 22. Global Recombinant Therapeutic Protein Sales (MT) by Type (2015-2020)
Table 23. Global Recombinant Therapeutic Protein Sales Share by Type (2015-2020)
Table 24. Global Recombinant Therapeutic Protein Revenue (US$ Million) Market Share by Type (2015-2020)
Table 25. Global Recombinant Therapeutic Protein Price (MT) by Type (2015-2020)
Table 26. Global Recombinant Therapeutic Protein Sales Share by Type (2021-2026)
Table 27. Global Recombinant Therapeutic Protein Revenue (US$ Million) Market Share by Type (2021-2026)
Table 28. Global Recombinant Therapeutic Protein Revenue Share by Type (2021-2026)
Table 29. Global Recombinant Therapeutic Protein Price (MT) by Type (2021-2026)
Table 30. Global Recombinant Therapeutic Protein Sales (MT) by Application (2015-2020)
Table 31. Global Recombinant Therapeutic Protein Sales Share by Application (2015-2020)
Table 32. Global Recombinant Therapeutic Protein Revenue (US$ Million) Market Share by Application (2015-2020)
Table 33. Global Recombinant Therapeutic Protein Price (MT) by Application (2015-2020)
Table 34. Global Recombinant Therapeutic Protein Sales (MT) by Application (2021-2026)
Table 35. Global Recombinant Therapeutic Protein Sales Share by Application (2021-2026)
Table 36. Global Recombinant Therapeutic Protein Revenue (US$ Million) Market Share by Application (2021-2026)
Table 37. Global Recombinant Therapeutic Protein Revenue Share by Application (2021-2026)
Table 38. Global Recombinant Therapeutic Protein Price (MT) by Application (2021-2026)
Table 39. United States Recombinant Therapeutic Protein Sales (MT) by Company (2015-2020)
Table 40. United States Recombinant Therapeutic Protein Sales Market Share by Company (2015-2020)
Table 41. United States Recombinant Therapeutic Protein Sales (MT) by Type (2015-2020)
Table 42. United States Recombinant Therapeutic Protein Sales Market Share by Type (2015-2020)
Table 43. United States Recombinant Therapeutic Protein Sales (MT) by Application (2015-2020)
Table 44. United States Recombinant Therapeutic Protein Sales Market Share by Application (2015-2020)
Table 45. Europe Recombinant Therapeutic Protein Sales (MT) by Company (2015-2020)
Table 46. Europe Recombinant Therapeutic Protein Sales Market Share by Company (2015-2020)
Table 47. Europe Recombinant Therapeutic Protein Sales (MT) by Type (2015-2020)
Table 48. Europe Recombinant Therapeutic Protein Sales Market Share by Type (2015-2020)
Table 49. Europe Recombinant Therapeutic Protein Sales (MT) by Application (2015-2020)
Table 50. Europe Recombinant Therapeutic Protein Sales Market Share by Type (2015-2020)
Table 51. China Recombinant Therapeutic Protein Sales (MT) by Company (2015-2020)
Table 52. China Recombinant Therapeutic Protein Sales Market Share by Company (2015-2020)
Table 53. China Recombinant Therapeutic Protein Sales (MT) by Type (2015-2020)
Table 54. China Recombinant Therapeutic Protein Sales Market Share by Type (2015-2020)
Table 55. China Recombinant Therapeutic Protein Sales (MT) by Application (2015-2020)
Table 56. China Recombinant Therapeutic Protein Sales Market Share by Application (2015-2020)
Table 57. Japan Recombinant Therapeutic Protein Sales (MT) by Company (2015-2020)
Table 58. Japan Recombinant Therapeutic Protein Sales Market Share by Company (2015-2020)
Table 59. Japan Recombinant Therapeutic Protein Sales (MT) by Type (2015-2020)
Table 60. Japan Recombinant Therapeutic Protein Sales Market Share by Type (2015-2020)
Table 61. Japan Recombinant Therapeutic Protein Sales (MT) by Application (2015-2020)
Table 62. Japan Recombinant Therapeutic Protein Sales Market Share by Application (2015-2020)
Table 63. Southeast Asia Recombinant Therapeutic Protein Sales (MT) by Company (2015-2020)
Table 64. Southeast Asia Recombinant Therapeutic Protein Sales Market Share by Company (2015-2020)
Table 65. Southeast Asia Recombinant Therapeutic Protein Sales (MT) by Type (2015-2020)
Table 66. Southeast Asia Recombinant Therapeutic Protein Sales Market Share by Type (2015-2020)
Table 67. Southeast Asia Recombinant Therapeutic Protein Sales (MT) by Type (2015-2020)
Table 68. Southeast Asia Recombinant Therapeutic Protein Sales Market Share by Application (2015-2020)
Table 69. India Recombinant Therapeutic Protein Sales (MT) by Company (2015-2020)
Table 70. India Recombinant Therapeutic Protein Sales Market Share by Company (2015-2020)
Table 71. India Recombinant Therapeutic Protein Sales (MT) by Type (2015-2020)
Table 72. India Recombinant Therapeutic Protein Sales Market Share by Type (2015-2020)
Table 73. India Recombinant Therapeutic Protein Sales (MT) by Application (2015-2020)
Table 74. India Recombinant Therapeutic Protein Sales Market Share by Application (2015-2020)
Table 75. Boehringer Ingelheim Corporation Information
Table 76. Boehringer Ingelheim Description and Business Overview
Table 77. Boehringer Ingelheim Recombinant Therapeutic Protein Sales (MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2015-2020)
Table 78. Boehringer Ingelheim Recombinant Therapeutic Protein Product
Table 79. Boehringer Ingelheim Recent Development
Table 80. Bristol-Myers Squibb Corporation Information
Table 81. Bristol-Myers Squibb Description and Business Overview
Table 82. Bristol-Myers Squibb Recombinant Therapeutic Protein Sales (MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2015-2020)
Table 83. Bristol-Myers Squibb Recombinant Therapeutic Protein Product
Table 84. Bristol-Myers Squibb Recent Development
Table 85. Celldex Therapeutics Corporation Information
Table 86. Celldex Therapeutics Description and Business Overview
Table 87. Celldex Therapeutics Recombinant Therapeutic Protein Sales (MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2015-2020)
Table 88. Celldex Therapeutics Recombinant Therapeutic Protein Product
Table 89. Celldex Therapeutics Recent Development
Table 90. Eli Liily Corporation Information
Table 91. Eli Liily Description and Business Overview
Table 92. Eli Liily Recombinant Therapeutic Protein Sales (MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2015-2020)
Table 93. Eli Liily Recombinant Therapeutic Protein Product
Table 94. Eli Liily Recent Development
Table 95. GlaxoSmithKline Corporation Information
Table 96. GlaxoSmithKline Description and Business Overview
Table 97. GlaxoSmithKline Recombinant Therapeutic Protein Sales (MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2015-2020)
Table 98. GlaxoSmithKline Recombinant Therapeutic Protein Product
Table 99. GlaxoSmithKline Recent Development
Table 100. Merck Corporation Information
Table 101. Merck Description and Business Overview
Table 102. Merck Recombinant Therapeutic Protein Sales (MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2015-2020)
Table 103. Merck Recombinant Therapeutic Protein Product
Table 104. Merck Recent Development
Table 105. Novartis Corporation Information
Table 106. Novartis Description and Business Overview
Table 107. Novartis Recombinant Therapeutic Protein Sales (MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2015-2020)
Table 108. Novartis Recombinant Therapeutic Protein Product
Table 109. Novartis Recent Development
Table 110. Regeneron Pharmaceuticals Corporation Information
Table 111. Regeneron Pharmaceuticals Recombinant Therapeutic Protein Sales (MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2015-2020)
Table 112. Regeneron Pharmaceuticals Description and Business Overview
Table 113. Regeneron Pharmaceuticals Recombinant Therapeutic Protein Product
Table 114. Regeneron Pharmaceuticals Recent Development
Table 115. Roche Corporation Information
Table 116. Roche Recombinant Therapeutic Protein Sales (MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2015-2020)
Table 117. Roche Description and Business Overview
Table 118. Roche Recombinant Therapeutic Protein Product
Table 119. Roche Recent Development
Table 120. Takeda Corporation Information
Table 121. Takeda Description and Business Overview
Table 122. Takeda Recombinant Therapeutic Protein Sales (MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2015-2020)
Table 123. Takeda Recombinant Therapeutic Protein Product
Table 124. Takeda Recent Development
Table 125. Production Base and Market Concentration Rate of Raw Material
Table 126. Key Suppliers of Raw Materials
Table 127. Recombinant Therapeutic Protein Distributors List
Table 128. Recombinant Therapeutic Protein Customers List
Table 129. Recombinant Therapeutic Protein Market Key Trends
Table 130. Recombinant Therapeutic Protein Key Opportunities and Drivers
Table 131. Recombinant Therapeutic Protein Market Challenges
Table 132. Research Programs/Design for This Report
Table 133. Key Data Information from Secondary Sources
Table 134. Key Data Information from Primary Sources
List of Figures
Figure 1. Recombinant Therapeutic Protein Product Picture
Figure 2. Global Recombinant Therapeutic Protein Sales Market Share by Type in 2020 & 2026
Figure 3. Type I Product Picture
Figure 4. Type II Product Picture
Figure 5. Global Recombinant Therapeutic Protein Market Share by Application in 2020 & 2026
Figure 6. Medicine Examples
Figure 7. Scientific Research Examples
Figure 8. Others Examples
Figure 9. Global Recombinant Therapeutic Protein Sales (MT) Growth Rate (2015-2026)
Figure 10. Global Recombinant Therapeutic Protein Revenue (US$ Million) Growth Rate (2015-2026)
Figure 11. Global Recombinant Therapeutic Protein Price Trends Growth Rate (2015-2026) (USD/MT)
Figure 12. Global Recombinant Therapeutic Protein Revenue Market Share by Region: 2015 VS 2020
Figure 13. Global Recombinant Therapeutic Protein Revenue Market Share by Region: 2021 VS 2026
Figure 14. United States Recombinant Therapeutic Protein Revenue (Million USD) Growth Rate (2015-2026)
Figure 15. United States Recombinant Therapeutic Protein Sales (MT) Growth Rate (2015-2026)
Figure 16. Europe Recombinant Therapeutic Protein Revenue (Million USD) Growth Rate (2015-2026)
Figure 17. Europe Recombinant Therapeutic Protein Sales (Million USD) Growth Rate (2015-2026)
Figure 18. China Recombinant Therapeutic Protein Revenue (Million USD) Growth Rate (2015-2026)
Figure 19. China Recombinant Therapeutic Protein Sales (Million USD) and Growth Rate (2015-2026)
Figure 20. Japan Recombinant Therapeutic Protein Revenue (Million USD) Growth Rate (2015-2026)
Figure 21. Japan Recombinant Therapeutic Protein Sales (Million USD) Growth Rate (2015-2026)
Figure 22. Southeast Asia Recombinant Therapeutic Protein Revenue (Million USD) Growth Rate (2015-2026)
Figure 23. Southeast Asia Recombinant Therapeutic Protein Sales (Million USD) Growth Rate (2015-2026)
Figure 24. India Recombinant Therapeutic Protein Revenue (Million USD) Growth Rate (2015-2026)
Figure 25. India Recombinant Therapeutic Protein Sales (Million USD) Growth Rate (2015-2026)
Figure 26. Global 5 Largest Recombinant Therapeutic Protein Players Market Share by Revenue in Recombinant Therapeutic Protein 2015 & 2019
Figure 27. Recombinant Therapeutic Protein Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2015 VS 2019
Figure 28. Global Recombinant Therapeutic Protein Revenue Share by Type (2015-2020)
Figure 29. Global Recombinant Therapeutic Protein Revenue Growth Rate by Type in 2015 & 2019
Figure 30. Global Recombinant Therapeutic Protein Revenue Share by Application (2015-2020)
Figure 31. Global Recombinant Therapeutic Protein Revenue Growth Rate by Application in 2015 & 2019
Figure 32. United States Recombinant Therapeutic Protein Sales Market Share by Type in 2019
Figure 33. United States Recombinant Therapeutic Protein Sales Market Share by Type in 2019
Figure 34. Europe Recombinant Therapeutic Protein Sales Market Share by Company in 2019
Figure 35. Europe Recombinant Therapeutic Protein Sales Market Share by Type in 2019
Figure 36. Europe Recombinant Therapeutic Protein Sales Market Share by Application in 2019
Figure 37. China Recombinant Therapeutic Protein Sales Market Share by Company in 2019
Figure 38. China Recombinant Therapeutic Protein Sales Market Share by Type in 2019
Figure 39. China Recombinant Therapeutic Protein Sales Market Share by Application in 2019
Figure 40. Japan Recombinant Therapeutic Protein Sales Market Share by Company in 2019
Figure 41. Japan Recombinant Therapeutic Protein Sales Market Share by Type in 2019
Figure 42. Japan Recombinant Therapeutic Protein Sales Market Share by Application in 2019
Figure 43. Southeast Asia Recombinant Therapeutic Protein Sales Market Share by Company in 2019
Figure 44. Southeast Asia Recombinant Therapeutic Protein Sales Market Share by Type in 2019
Figure 45. Southeast Asia Recombinant Therapeutic Protein Sales Market Share by Application in 2019
Figure 46. India Recombinant Therapeutic Protein Sales Market Share by Company in 2019
Figure 47. India Recombinant Therapeutic Protein Sales Market Share by Type in 2019
Figure 48. India Recombinant Therapeutic Protein Sales Market Share by Application in 2019
Figure 49. Key Raw Materials Price Trend
Figure 50. Manufacturing Cost Structure of Recombinant Therapeutic Protein
Figure 51. Manufacturing Process Analysis of Recombinant Therapeutic Protein
Figure 52. Recombinant Therapeutic Protein Industrial Chain Analysis
Figure 53. Channels of Distribution
Figure 54. Distributors Profiles
Figure 55. Porter's Five Forces Analysis
Figure 56. Bottom-up and Top-down Approaches for This Report
Figure 57. Data Triangulation
Figure 58. Key Executives Interviewed
組換えグリコシル化タンパク質の世界市場レポート2020 Market Analysis and Insights: Global Recombinant Glycosylated Protein Market The global Recombinant Glycosylated Protein market size is projected to reach US$ XX million by 2026, from US$ XX million in 2020, at a CAGR of XX% during 2021-2026. Global Recombinant Glycosylated Protein Scope and Market …- 組換え非グリコシル化タンパク質の世界市場レポート2020 Market Analysis and Insights: Global Recombinant Non-glycosylated Protein Market The global Recombinant Non-glycosylated Protein market size is projected to reach US$ XX million by 2026, from US$ XX million in 2020, at a CAGR of XX% during 2021-2026. Global Recombinant Non-glycosylated Protein Scope…
- 組換えヒト血清アルブミンの世界市場レポート2020 Recombinant Human Serum Albumin (Rec. HSA) is animal origin free expressed in E.coli without animal or human derived raw materials. It is also free from other contaminating serum proteins. Recombinant human serum albumin (rHSA) is genetically engineered and derived from a rice-based expression syste…
- 組換えヒトエンドスタチンの世界市場レポート2020 Endostatin is a naturally occurring, 20-kDa C-terminal fragment derived from type XVIII collagen. Human monomeric endostatin is a globular protein containing two disulfide bonds: Cys162−302 and Cys264−294. Market Analysis and Insights: Global Recombinant Human Endostatin Market The global Recombinan…
- 組換えトリプシンの世界市場レポート2020 Market Analysis and Insights: Global Recombinant Trypsin Market The global Recombinant Trypsin market size is projected to reach US$ 44 million by 2026, from US$ 27 million in 2020, at a CAGR of 8.2% during 2021-2026. Global Recombinant Trypsin Scope and Market Size The global Recombinant Trypsin ma…